ACAD vs GILD: Which Stock is Better?

Side-by-side comparison of ACADIA Pharmaceuticals Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ACAD

ACADIA Pharmaceuticals Inc

GILD

Gilead Sciences Inc

$129.83

Key Metrics Comparison

MetricACADGILDWinner
Market Cap$3.51B$160.15BGILD
P/E Ratio15.2917.55ACAD
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze ACAD

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACAD or GILD a better investment?

Comparing ACAD and GILD: ACADIA Pharmaceuticals Inc has a market cap of $3.51B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACAD and GILD?

ACAD (ACADIA Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACAD or GILD?

Based on P/E ratios, ACAD trades at a lower multiple (15.3x vs 17.5x).

Which is growing faster: ACAD or GILD?

Both ACAD and GILD show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: ACAD or GILD?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: ACAD or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $3.51B for ACAD.

Should I buy ACAD or GILD in 2026?

Both ACAD and GILD have investment merit. ACAD trades at $N/A while GILD trades at $129.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACAD and GILD stock?

Key differences: Market Cap ($3.51B vs $160.15B), P/E Ratio (15.3x vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy ACAD or GILD in 2026?

The choice between ACAD and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between ACAD and GILD?

ACAD (ACADIA Pharmaceuticals Inc) has a market cap of $3.51B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.

Popular Stock Comparisons